Manish Srivastava (Sophrosyne Technologies)

Overview

Manish Srivastava is an Indian entrepreneur and co-founder of Sophrosyne Technologies, a fabless semiconductor startup based in Bangalore, India. Established in 2022, the company focuses on developing advanced biosensing system-on-chip (SoC) solutions primarily for wearable and digital-health devices. The firm aims to revolutionize the field of health monitoring by integrating multiple vital sign measurements into compact, energy-efficient chips suitable for next-generation medical and fitness devices.

Recent Developments

As of November 2025, Sophrosyne Technologies has made significant strides in the semiconductor industry under the leadership of Manish Srivastava. Noteworthy developments in recent years include:

November 2025: Sophrosyne Technologies raised $2 million in a seed funding round led by Bluehill.VC, a deep-tech venture capital firm known for supporting breakthrough engineering and science domains. This investment aims to transition Sophrosyne from prototype silicon to full-scale production and expand its silicon design and firmware teams.
2025: The company cleared technical diligence and was awarded a $1.2 million Design Linked Incentive (DLI) grant from the Ministry of Electronics and Information Technology (MeitY) of India. This grant endorses the startup's technological roadmap and engineering prowess.
2024: Sophrosyne Innovation Lab and Sophrosyne Semiconductor were established, with Srivastava serving as a director, enhancing the company's research and development capabilities and broadening its scope in the semiconductor industry.

These advances highlight the growing interest and financial backing for Sophrosyne Technologies as it continues to innovate in the field of semiconductor biosensing technology.

Personal Information

Attribute	Information
Full Name	Manish Srivastava
Born	Not publicly available
Nationality	Indian
Occupation	Entrepreneur, Semiconductor Innovator
Known For	Co-founding Sophrosyne Technologies
Net Worth	Not publicly disclosed
Education	Not publicly available

Early Life and Education

There is limited public information regarding the early life and educational background of Manish Srivastava. What is evident, however, is that Srivastava's career path has been significantly shaped by his deep-seated interest and expertise in semiconductor technology and digital health solutions. This foundation has been pivotal in his capability to navigate and innovate within the competitive landscape of semiconductor startups.

Career and Notable Achievements

Manish Srivastava's professional journey prominently features the founding and growth of Sophrosyne Technologies:

2022: Co-founded Sophrosyne Technologies alongside Jatin Gupta. The main focus was the development of an advanced biosensing SoC, which integrates multiple sensor functions for wearable health devices, marking a significant leap in health monitoring technology.
2024-2025: Led strategic expansions within the company, including the inauguration of the Sophrosyne Innovation Lab and Sophrosyne Semiconductor, furthering research and development initiatives.
2025: Secured $2 million seed funding from Bluehill.VC to propel the company's biosensing chips into broader commercial availability and extend its engineering teams.

These milestones underscore Srivastava’s vision and leadership in advancing technology that supports continuous and precise health data acquisition.

Current Work and Impact

Currently, Manish Srivastava continues to oversee the strategic direction and technological advancements of Sophrosyne Technologies. The company's pioneering SoCs are making significant impacts in the wearable technology sector, particularly in health monitoring. Their innovative approach to integrating various biosensing capabilities into a single, power-efficient chip positions them at the forefront of wearable health tech, influencing both consumer health devices and medical applications globally.

Conclusion

Manish Srivastava, through his work with Sophrosyne Technologies, is contributing significantly to the semiconductor and wearable tech industries. The focus on energy-efficient, multi-sensory chips addresses a critical need in health technology, promising enhanced capabilities for future health-monitoring devices. As Sophrosyne advances and scales its operations globally, Srivastava’s leadership likely will play a critical role in shaping the landscape of digital health solutions, marking a lasting influence on both the technology and health sectors.